For the Quarter Ending March 2026
听
Metoprolol Succinate Prices in听North America
- In United States, the Metoprolol Succinate Price Index rose quarter-over-quarter in Q1 2026, reflecting elevated production costs.
- The Metoprolol Succinate Production Cost Trend increased in March 2026 as producer prices rose 4.0% year-over-year.
- The Metoprolol Succinate Price Index climbed in March 2026, supported by a 3.3% year-over-year consumer inflation rate.
- The Metoprolol Succinate Demand Outlook stayed robust in March 2026, backed by 4.0% year-over-year retail sales growth.
- Unemployment at 4.3% in March 2026 sustained health insurance coverage, securing steady cardiovascular medication consumption.
- Consumer confidence hit 91.8 in March 2026, ensuring patients prioritized essential chronic disease management over discretionary spending.
- Industrial production grew 0.7% in March 2026, while the Manufacturing Index expanded, ensuring reliable supply chains.
- Henry Hub natural gas feedstock prices surged in January 2026 before softening in February and March 2026.
- The Metoprolol Succinate Price Forecast indicated upward pressure during Q1 2026 due to tightening global energy supplies.
Why did the price of Metoprolol Succinate change in March 2026 in North America?
- Producer prices rose 4.0% in March 2026, directly elevating active pharmaceutical ingredient synthesis input costs.
- Consumer inflation reached 3.3% in March 2026, increasing transportation and logistics expenses for pharmaceutical distribution.
- International natural gas prices spiked in March 2026, driving up baseline energy costs for manufacturing.
听
Metoprolol Succinate Prices in听APAC
- In China, the Metoprolol Succinate Price Index rose quarter-over-quarter in Q1 2026, driven by surging upstream chemical feedstock costs.
- The Metoprolol Succinate Production Cost Trend increased in March 2026 as the PPI rose by 0.5 percent.
- The Metoprolol Succinate Demand Outlook remained stable in March 2026, supported by a 1.0 percent CPI increase.
- Industrial production grew by 5.7 percent in March 2026, ensuring ample availability for Metoprolol Succinate precursor synthesis.
- Retail sales grew 1.7 percent and unemployment reached 5.4 percent in March 2026, limiting premium formulation demand.
- The regional Manufacturing Index expanded in March 2026, despite consumer confidence dropping to 91.6 in February 2026.
- Upstream naphtha costs surged in early March 2026 because Middle East conflicts disrupted regional energy resupply flows.
- The Metoprolol Succinate Price Forecast reflected upward pressure in Q1 2026 as delivered crude glycerine costs firmed.
Why did the price of Metoprolol Succinate change in March 2026 in APAC?
- Naphtha inventories depleted rapidly in March 2026 as Middle East conflicts disrupted Asian resupply flows.
- Delivered pricing for crude glycerine firmed in Q1 2026 due to elevated container freight costs.
- Petrochemical producers cut output in March 2026 due to severe feedstock supply uncertainty in Asia.
听
Metoprolol Succinate Prices in听Europe
- In Germany, the Metoprolol Succinate Price Index rose quarter-over-quarter in Q1 2026, driven by surging upstream feedstock costs.
- The Metoprolol Succinate Production Cost Trend increased in March 2026 as inflation reached 2.7%, elevating operational expenses.
- Propylene feedstock costs settled higher in March 2026, directly pushing the Metoprolol Succinate Price Index upward.
- The Metoprolol Succinate Demand Outlook weakened as pharmaceutical manufacturing output plummeted in January 2026 and contracted in February 2026.
- Producer prices fell 0.2% in March 2026, while industrial production remained stagnant at 0.0% in February 2026.
- Retail sales grew 0.7% and unemployment stayed at 4.2% in February 2026, supporting baseline pharmacy dispensing.
- Consumer confidence hit -24.7 in March 2026, negatively impacting the short-term Metoprolol Succinate Price Forecast.
- The Manufacturing Index expanded in March 2026, tightening the supply of shared chemical intermediates for pharmaceutical synthesis.
Why did the price of Metoprolol Succinate change in March 2026 in Europe?
- Brent crude oil and naphtha precursor costs surged significantly during March 2026, elevating production expenses.
- Petrochemical building block supply faced severe disruptions due to Middle East conflicts in March 2026.
- General inflation rose to 2.7% in March 2026, increasing utility and labor costs for synthesis.
For the Quarter Ending December 2025
听
Metoprolol Succinate in APAC
- In China, Metoprolol Succinate Price Index declined in Q4 2025, influenced by decreasing producer input costs.
- Metoprolol Succinate production costs decreased, with Producer Price Index falling 1.9% in December 2025.
- Pharmaceutical demand in China expanded robustly throughout 2025, driven by an aging population and rising per-capita spending.
- The Metoprolol Succinate price forecast suggests continued downward pressure due to sustained chemical sector overcapacity.
- China's Manufacturing Index expanded in December 2025, supporting stable supply chain efficiency for production.
- Oversupply in the broader chemical sector and elevated inventories persisted throughout 2025, impacting market balance.
- Industrial production grew 5.2% in December 2025, indicating a robust manufacturing sector supporting supply.
- Low Consumer Price Index (0.8%) and retail sales growth (0.9%) in December 2025 reflected weak consumer demand.
- A stable unemployment rate of 5.1% in December 2025 supported consistent income and healthcare access.
Why did the price of Metoprolol Succinate change in December 2025 in APAC?
- Producer input costs declined, with the Producer Price Index falling 1.9% in December 2025.
- Persistent chemical sector overcapacity throughout 2025 contributed to elevated inventories and price pressure.
- Weak overall consumption and decelerated economic growth in Q4 2025 impacted market sentiment.
听
Metoprolol Succinate in听Europe
- In Germany, the Metoprolol Succinate Price Index fell quarter-over-quarter in Q4 2025, influenced by contracting manufacturing activity in December 2025.
- Metoprolol Succinate production costs were impacted by comparatively high natural gas prices in late 2025.
- The Producer Price Index declined by 2.5% year-on-year in December 2025, reducing raw material costs.
- Metoprolol Succinate demand outlook was dampened by a plummeting chemical industry business climate in October 2025.
- Consumer confidence in Germany registered -17.5 in December 2025, affecting healthcare spending.
- Industrial production in Germany inched up by 0.8% year-on-year in October 2025, supporting manufacturing.
- The unemployment rate in Germany reached 6.2% in December 2025, impacting patient access.
- Increased natural gas levies and a rising CO2 price in 2025 contributed to higher energy costs.
- Retail sales grew by 1.1% year-on-year in November 2025, indicating consumer purchasing power.
- A 1.8% year-on-year Consumer Price Index in December 2025 indicated inflationary pressure on operational costs.
Why did the price of Metoprolol Succinate change in December 2025 in Europe?
- Weak demand drivers, including plummeting chemical industry business climate in October 2025.
- Producer Price Index declined by 2.5% year-on-year in December 2025, lowering input costs.
- High natural gas prices in late 2025 and increased CO2 levies raised energy expenses.
听
Metoprolol Succinate in听North America
- In the United States, the Metoprolol Succinate Price Index rose quarter-over-quarter in Q4 2025, driven by escalating production costs.
- Metoprolol Succinate production costs increased due to a 3.0% rise in PPI year-over-year in November 2025.
- Demand for Metoprolol Succinate strengthened, supported by a 2.0% increase in industrial production in December 2025.
- The Metoprolol Succinate Price Forecast indicates continued upward pressure from elevated energy feedstock costs in 2025.
- Overall U.S. health spending increased in 2025, positively impacting Metoprolol Succinate demand outlook.
- A 2.7% year-over-year CPI increase in December 2025 raised raw material and labor costs for manufacturing.
- Imports of pharmaceutical preparations decreased in October 2025, tightening Metoprolol Succinate supply dynamics.
- Robust consumer spending, with retail sales up 3.3% in November 2025, supported Metoprolol Succinate demand.
- A 4.4% unemployment rate in December 2025 indicated a strong labor market, boosting healthcare access.
Why did the price of Metoprolol Succinate change in December 2025 in North America?
- Production costs for Metoprolol Succinate rose due to a 3.0% PPI increase in November 2025.
- Demand for Metoprolol Succinate was supported by growing prescription drug spending in 2025.
- Decreased imports of pharmaceutical preparations in October 2025 tightened regional supply.
For the Quarter Ending September 2025
听
Metoprolol Succinate Prices in听North America
- In USA, the Metoprolol Succinate Price Index rose by 2.63% quarter-over-quarter, driven by modest supply tightening.
- The average Metoprolol Succinate price for the quarter was approximately USD 54790.00/MT, based on settlements.
- Metoprolol Succinate Spot Price remained stable as contract rollovers supported the Price Index and margins.
- Metoprolol Succinate Price Forecast indicates limited upside near term given balanced inventories and steady demand.
- Rising feedstock costs modestly affected the Metoprolol Succinate Production Cost Trend, pressuring some contract renewal levels.
- Metoprolol Succinate Demand Outlook is steady from generics and buying, cushioning against Price Index declines.
- Inventory drawdowns improved export availability, supporting the Metoprolol Succinate Price Index despite soft spot activity.
- Several manufacturers operated normally with limited outages, sustaining supply, stabilizing the Metoprolol Succinate Price Index.
Why did the price of Metoprolol Succinate change in September 2025 in North America?
- Tighter contract allocations reduced available spot volumes, tightening supply versus steady demand and supporting prices.
- Higher active pharmaceutical ingredient feedstock costs and increased freight rates elevated production costs and pressured margins.
- Stable procurement by generic manufacturers and limited factory outages maintained demand certainty, constraining downward Price Index movement.
听
Metoprolol Succinate Prices in听APAC
- In China, the Metoprolol Succinate Price Index rose by 2.6% quarter-over-quarter in Q3 2025, reflecting modest demand recovery.
- The average Metoprolol Succinate price for the quarter was approximately USD 54650.00/MT, reflecting contract settlements.
- Metoprolol Succinate Spot Price displayed limited volatility as buyers awaited contract conclusions and inventory adjustments.
- Metoprolol Succinate Price Forecast remains cautiously positive due to steady offtake and constrained supply availability.
- Metoprolol Succinate Production Cost Trend indicated pressure from raw material import costs and energy tariffs.
- Metoprolol Succinate Demand Outlook strengthened for generics manufacturing and hospital restocking, supporting tighter market balances.
- Metoprolol Succinate Price Index movements correlated with export nominations and inventory draws at coastal terminals.
- Operational disruptions at select Metoprolol Succinate producers tightened availability, influencing buying and contract renewal behaviors.
Why did the price of Metoprolol Succinate change in September 2025 in APAC?
- Stronger institutional purchases reduced readily available inventories, tightening supply and supporting marginal price increases domestically.
- Higher material import costs and energy tariffs increased production cost pressure, constraining margins for manufacturers.
- Logistics congestion and phased export nominations delayed shipments, amplifying tightness and accelerating contract negotiations activity.
听
Metoprolol Succinate Prices in听Europe
- In Germany, the Metoprolol Succinate Price Index rose by 2.595% quarter-over-quarter, driven by limited supply.
- The average Metoprolol Succinate price for the quarter was approximately USD 54730/MT, reported by sources.
- Metoprolol Succinate Spot Price gains reflected constrained European synthesis capacity while Price Index signaled tightening.
- Rising raw material and energy costs pushed the Metoprolol Succinate Production Cost Trend, pressuring margins.
- The Metoprolol Succinate Demand Outlook improved due to stable generic uptake and hospital procurement cycles.
- Near-term Metoprolol Succinate Price Forecast suggests upward bias amid steady export demand and low inventories.
- Operational disruptions at key German producers tightened availability, reflecting in the Metoprolol Succinate Price Index.
- Inventory drawdowns and recent tender awards supported Metoprolol Succinate price resilience despite competitive import offers.
Why did the price of Metoprolol Succinate change in September 2025 in Europe?
- Supply tightness from maintenance and regulatory lead times reduced available volumes, lifting market prices short-term.
- Higher feedstock and energy costs increased production expenses, translating into upward pressure on supplier pricing.
- Improved procurement activity and export demand combined with logistic constraints to tighten availability regionally notably.
For the Quarter Ending March 2025
North America
The U.S. Metoprolol Succinate market experienced a gradual yet consistent price increase across Q1 2025, driven by a combination of supply constraints, trade policy shifts, and rising operational costs. January saw a modest price uptick as U.S. importers front-loaded shipments to avoid the impending 10% tariff on Chinese goods set for February 1. This pre-tariff inventory build-up, combined with Chinese Lunar New Year-related demand and higher energy costs, created short-term supply pressure and minor price escalation. Additional strain emerged from port congestion in California, triggered by wildfire-related labor shortages and adverse weather, marginally increasing dwell times and shipping costs.
In February, prices rose more sharply as the 10% tariff took effect, raising landed costs and intensifying procurement challenges. Export prices from China surged amid strong international demand and manufacturing cost inflation, further driving price gains. Slower deliveries and falling inventories amplified the strain, while a revival in industrial output and consumer sentiment fueled demand growth.
March continued the upward trend, with added complexity from China鈥檚 retaliatory tariff hike to 125%, escalating sourcing costs. Despite easing logistics charges, elevated raw material prices and steady pharmaceutical demand maintained a tight supply landscape. Proactive inventory strategies prevailed as buyers navigated persistent supply-side inflation and geopolitical uncertainty.
Asia Pacific
Throughout Q1 2025, Metoprolol Succinate prices in China trended upward, supported by firm pharmaceutical demand, seasonal supply disruptions, and intensified global trade activity. In January, prices recorded a modest increase, driven by steady offtake from healthcare sectors and reduced production activity ahead of the Lunar New Year. As manufacturers scaled back operations during the holiday period, inventory replenishment efforts by pharmaceutical buyers created mild supply tightness. Exporters also expedited shipments in anticipation of the impending U.S. tariff hike, marginally impacting domestic availability and supporting slight price gains.
February witnessed a more pronounced price increase amid tightening inventories and sustained downstream demand. Rising raw material costs and trade-related uncertainty, especially following the U.S. implementation of a 10% import tariff, led to heightened volatility. The resulting wave of bulk purchases by international buyers contributed to supply constraints. A rebound in China鈥檚 PMI, reflecting renewed industrial activity, further reinforced pharmaceutical demand and pricing momentum.
In March, export prices surged significantly as inventories declined and overseas procurement accelerated due to escalating U.S.鈥揅hina trade tensions. With the PMI reaching a year-high of 50.5, domestic industrial output surged, pushing up raw material costs. Strong international interest, supported by lower freight rates, sustained the bullish pricing trajectory through quarter-end.
Europe
During Q1 2025, Metoprolol Succinate prices in Germany followed a gradually upward trajectory, supported by stable downstream demand and mounting cost pressures from origin markets. In January, prices saw a minor increase as sentiment in the German economy improved, encouraging moderate growth in new orders from the pharmaceutical sector. While early Lunar New Year demand from Asia and Red Sea logistics disruptions led to extended lead times, efficient supply chain management and adequate inventories ensured market stability, contributing only modestly to price movement.
February marked a continuation of this upward trend, driven by low domestic inventories and strengthening demand. The depreciation of the euro against the U.S. dollar elevated procurement costs, while firm pricing in China鈥擥ermany鈥檚 key supplier鈥攁dded upward pressure. Although freight rates declined, offering marginal cost relief, they were insufficient to fully counteract the impact of rising input costs and steady consumption by pharmaceutical and healthcare industries.
By March, pricing momentum accelerated as Chinese export prices climbed further due to higher production costs, directly influencing import values. Germany鈥檚 improving Manufacturing PMI and declining inflation signaled stronger economic fundamentals, which supported firm demand. Despite ongoing currency volatility, the consistent offtake from pharmaceutical manufacturers and solid international sourcing costs sustained the bullish trend across the German Metoprolol Succinate market.
